Ahead of Print -Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands1 - Volume 21, Number 8—August 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 8—August 2015
Research
Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands1
On This Page
Stephan P. Keijmel , Elmer Krijger, Corine E. Delsing, Tom Sprong, Marrigje H. Nabuurs-Franssen, and Chantal P. Bleeker-Rovers
Abstract
Differentiating acute Q fever from infections caused by other pathogens is essential. We conducted a retrospective case–control study to evaluate differences in clinical signs, symptoms, and outcomes for 82 patients with acute Q fever and 52 control patients who had pneumonia, fever and lower respiratory tract symptoms, or fever and hepatitis, but had negative serologic results for Q fever. Patients with acute Q fever were younger and had higher C-reactive protein levels but lower leukocyte counts. However, a large overlap was found. In patients with an indication for prophylaxis, chronic Q fever did not develop after patients received prophylaxis but did develop in 50% of patients who did not receive prophylaxis. Differentiating acute Q fever from other respiratory infections, fever, or hepatitis is not possible without serologic testing or PCR. If risk factors for chronic Q fever are present, prophylactic treatment is advised.
Q fever is a zoonosis caused by the bacterium Coxiella burnetii. During 2007–2010, the southern part of the Netherlands had the largest outbreak of Q fever ever reported (1,2). Infection with C. burnetii is symptomatic in ≈40% of all patients (3). Clinical signs range from a mild influenza-like illness to pneumonia or a hepatitis-like syndrome and can differ by region (4,5). After initial infection, chronic Q fever will develop in 1%–5% of patients (1,3). Furthermore, long-lasting fatigue will develop in ≈20% of all patients with symptomatic acute Q fever (6–8) without development of chronic Q fever (9).
Treatment for acute infection decreases the duration of fever, increases recovery from pneumonia (10), and might lead to a lower percentage of patients in whom chronic Q fever will develop (10–13). In addition, several reports indicate that, in acute Q fever patients at risk for development of chronic Q fever, prophylactic treatment might prevent persistent infection (12,14). Therefore, recognizing Q fever in an early stage is a useful strategy.
The only available data on symptoms of acute Q fever in the Netherlands were obtained from a retrospective study that collected data several months after onset of disease by sending questionnaires to patients with acute Q fever (15). However, this method for obtaining data is limited by a high risk for recall bias. To facilitate physicians in differentiating acute Q fever from other diseases, a clear description of signs and symptoms compatible with C. burnetii infection is desirable.
The purpose of this case–control study was to evaluate differences in clinical signs and symptoms between patients with acute Q fever referred to a hospital and a control group of patients with signs and symptoms that led to addition of Q fever in the differential diagnosis. Furthermore, outcome of patients hospitalized with acute Q fever were evaluated, and the effect of prophylactic treatment for those patients with an indication to prevent development of chronic Q fever was analyzed.
Mr. Keijmel is an MD/PhD candidate at the Radboud University Medical Center, Nijmegen, the Netherlands. His research activities focus on long-term consequences of Q fever.
Acknowledgment
We thank Ton Dofferhoff for collecting data and treating several patients.
References
- Delsing CE, Kullberg BJ, Bleeker-Rovers CP. Q fever in the Netherlands from 2007 to 2010. Neth J Med. 2010;68:382–7 .PubMed
- Tilburg JJ, Rossen JW, van Hannen EJ, Melchers WJ, Hermans MH, van de Bovenkamp J, Genotypic diversity of Coxiella burnetii in the 2007–2010 Q fever outbreak episodes in The Netherlands. J Clin Microbiol. 2012;50:1076–8 . DOIPubMed
- Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999;12:518–53 .PubMed
- Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol. 1998;36:1823–34 .PubMed
- Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005;5:219–26. DOIPubMed
- Wildman MJ, Smith EG, Groves J, Beattie JM, Caul EO, Ayres JG. Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort. QJM. 2002;95:527–38. DOIPubMed
- Keijmel SP, Morroy G, Delsing CE, Bleijenberg G, Bleeker-Rovers CP, Timen A. Persistent fatigue following Q fever [in Dutch]. Ned Tijdschr Geneeskd. 2012;156:A5258 .PubMed
- Morroy G, Peters JB, van Nieuwenhof M, Bor HHJ, Hautvast JLA, van der Hoek W, The health status of Q-fever patients after long-term follow-up.BMC Infect Dis. 2011;11:97. DOIPubMed
- The Dutch Working Group Q fever fatigue syndrome. Dutch guideline Q fever fatigue syndrome, 2012 [in Dutch] [cited 2015 Mar 31].http://www.rivm.nl/Bibliotheek/Professioneel_Praktisch/Richtlijnen/Infectieziekten/LCI_richtlijnen/LCI_richtlijn_Q_koortsvermoeidheidssyndroom_QVS
- Marrie TJ. Coxiella burnetii pneumonia. Eur Respir J. 2003;21:713–9. DOIPubMed
- Dijkstra F, Riphagen-Dalhuisen J, Wijers N, Hak E, van der Sande MAB, Morroy G, Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiol Infect. 2011;139:1332–41. DOIPubMed
- Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis.2001;33:312–6. DOIPubMed
- Kampschreur LM, Dekker S, Hagenaars JC, Lestrade PJ, Renders NH, de Jager-Leclercq MG, Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis. 2012;18:563–70. DOIPubMed
- Million M, Walter G, Thuny F, Habib G, Raoult D. Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin Infect Dis. 2013;57:836–44. DOIPubMed
- Karagiannis I, Schimmer B, Van Lier A, Timen A, Schneeberger P, Van Rotterdam B, Investigation of a Q fever outbreak in a rural area of The Netherlands. Epidemiol Infect. 2009;137:1283–94. DOIPubMed
- Wegdam-Blans MC, Nabuurs-Franssen MN, Horrevorts AM, Peeters MF, Schneeberger PM, Bijlmer HA. Laboratory diagnosis of acute Q fever [in Dutch]. Ned Tijdschr Geneeskd. 2010;154:A2388 .PubMed
- Spelman DW. Q fever: a study of 111 consecutive cases. Med J Aust. 1982;1:547–8, 551, 553 .PubMed
- Morovic M. Q fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only? Am J Trop Med Hyg. 2005;73:947–8.PubMed
- Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54. DOIPubMed
- Mehta CR, Senchaudhuri P. Conditional versus unconditional exact tests for comparing two binomials. Cambridge (MA): Cytel Software Corporation; 2003 [cited 2015 Mar 31]. http://www.cytel.com/papers/twobinomials.pdf
- Orr HJ, Christensen H, Smyth B, Dance DA, Carrington D, Paul I, Case-control study for risk factors for Q fever in southwest England and Northern Ireland. Euro Surveill. 2006;11:260–2 .PubMed
- Parker NR, Barralet JH, Bell AM. Q fever. Lancet. 2006;367:679–88. DOIPubMed
- Honarmand H. Q fever: an old but still a poorly understood disease. Interdiscip Perspect Infect Dis. 2012;1012:6131932 .DOIPubMed
- Delsing CE, Bleeker-Rovers CP, Nabuurs-Franssen M, Sprong T, van der Ven AJ, Kullberg BJ. Q fever, a potential serious disease [in Dutch]. Ned Tijdschr Geneeskd. 2009;153:652–7 .PubMed
- van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010;15:19520 .PubMed
- Wielders CC, Wuister AM, de Visser VL, de Jager-Leclercq MG, Groot CA, Dijkstra F, Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands. PLoS ONE. 2014;9:e91764. DOIPubMed
- Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82. DOIPubMed
- Dutch Working Party on Antibiotic Policy. Guidelines for diagnosis and treatment of community-acquired pneumonia in adults, 2011 [cited 2015 Jun 3]. http://www.swab.nl/swab/cms3.nsf/uploads/48C3A8CABEA7C8AAC12578B2004798A7/$FILE/CAP_SWAB_concept150611.pdf
- Schouten JA, Prins JM, Bonten MJ, Degener J, Janknegt RE, Hollander JM, Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med. 2005;63:323–35 .PubMed
- Kampschreur LM, Oosterheert JJ, Wever PC, Bleeker-Rovers CP. Antibiotic prophylaxis for high-risk patients with acute Q fever: no definitive answers yet. Clin Infect Dis. 2014;58:446–7. DOIPubMed
- Limonard GJ, Nabuurs-Franssen MH, Weers-Pothoff G, Wijkmans C, Besselink R, Horrevorts AM, One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection. 2010;38:471–7. DOIPubMed
- van der Hoek W, Versteeg B, Meekelenkamp JC, Renders NH, Leenders AC, Weers-Pothoff I, Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis. 2011;52:1431–6. DOIPubMed
- Keijmel S, van Kasteren M, Blokx W, van der Meer J, van Rossum M, Bleeker-Rovers C. Cutaneous hyperpigmentation induced by doxycycline: a case series. Neth J Med. 2015;73:37–40.
- Wegdam-Blans MC, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect. 2012;64:247–59. DOIPubMed
- Marmion BP, Shannon M, Maddocks I, Storm P, Penttila I. Protracted debility and fatigue after acute Q fever. Lancet. 1996;347:977–8.DOIPubMed
- Limonard GJ, Nabuurs-Franssen MH, Weers-Pothoff G, Wijkmans C, Besselink R, Horrevorts AM, One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection. 2010;38:471–7. DOIPubMed
Tables
Suggested citation for this article: Keijmel SP, Krijger E, Delsing CE, Sprong T, Nabuurs-Franssen MH, Bleeker-Rovers CP. Differentiation of acute Q fever from other infections in patients presenting to hospitals, the Netherlands. Emerg Infect Dis. 2015 Aug [date cited].http://dx.doi.org/10.3201/eid2108.140196
1Preliminary results from this study were presented as a poster (P1851) at the 22th annual European Congress of Clinical Microbiology and Infectious Diseases, March 31–April 3, 2012, London, UK.
No hay comentarios:
Publicar un comentario